Hilary Daniel, BS; Sue S. Bornstein, MD; for the Health and Public Policy Committee of the American College of Physicians *
Financial Support: Financial support for the development of this position paper came exclusively from the ACP operating budget.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-0035.
Corresponding Author: Hilary Daniel, BS, American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001; e-mail, hdaniel@mail.acponline.org.
Current Author Addresses: Ms. Daniel: American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001.
Dr. Bornstein: 3111 Beverly Drive, Dallas, TX 75205.
Author Contributions: Conception and design: H. Daniel, S.S. Bornstein, J.D. Lenchus, J. Quinton.
Analysis and interpretation of the data: H. Daniel, J.K. Carney, T.G. Cooney, T.L. Henry, J.D. Lenchus, M.B. Southworth.
Drafting of the article: H. Daniel, F. Syed.
Critical revision of the article for important intellectual content: H. Daniel, S.S. Bornstein, J.K. Carney, T.G. Cooney, L.S. Engel, T.L. Henry, J.D. Lenchus, M.B. Southworth, J. Quinton, M.A. Wallace.
Final approval of the article: H. Daniel, S.S. Bornstein, J.K. Carney, T.G. Cooney, L.S. Engel, H.E. Gantzer, T.L. Henry, J.D. Lenchus, B.M. McCandless, M.B. Southworth, F. Syed, J. Quinton, M.A. Wallace, A. Valdrighi.
Administrative, technical, or logistic support: H. Daniel, T.L. Henry.
Collection and assembly of data: H. Daniel.
Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.
Daniel H, Bornstein SS, for the Health and Public Policy Committee of the American College of Physicians. Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians. Ann Intern Med. 2019;171:823–824. [Epub ahead of print 12 November 2019]. doi: https://doi.org/10.7326/M19-0035
Download citation file:
© 2019
Published: Ann Intern Med. 2019;171(11):823-824.
DOI: 10.7326/M19-0035
Published at www.annals.org on 12 November 2019
Healthcare Delivery and Policy.
Results provided by: